Estats Units - anglès - NLM (National Library of Medicine)

blenheim pharmacal, inc. - hydroxychloroquine sulfate (unii: 8q2869cnvh) (hydroxychloroquine - unii:4qwg6n8qkh) - hydroxychloroquine sulfate tablets are indicated for the suppressive treatment and treatment of acute attacks of malaria due to plasmodium vivax , p. malariae , p. ovale , and susceptible strains of p. falciparum . hydroxychloroquine sulfate tablets are also indicated for the treatment of discoid and systemic lupus erythematosus, and rheumatoid arthritis. use of this drug is contraindicated (1) in the presence of retinal or visual field changes attributable to any 4-aminoquinoline compound, (2) in patients with known hypersensitivity to 4-aminoquinoline compounds, and (3) for long-term therapy in children.

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

bristol laboratories ltd - hydroxychloroquine sulfate - oral tablet - 200mg

Estats Units - anglès - NLM (National Library of Medicine)

golden state medical supply, inc. - chloroquine phosphate (unii: 6e17k3343p) (chloroquine - unii:886u3h6uff) - chloroquine phosphate 250 mg

Estats Units - anglès - NLM (National Library of Medicine)

bryant ranch prepack - chloroquine phosphate (unii: 6e17k3343p) (chloroquine - unii:886u3h6uff) - chloroquine phosphate 250 mg

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - hydroxychloroquine sulfate - oral tablet - 200mg

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

blackrock pharmaceuticals ltd - hydroxychloroquine sulfate - oral tablet - 200mg

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - hydroxychloroquine sulfate - oral tablet - 200mg

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - hydroxychloroquine sulfate - oral tablet - 200mg

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

kent pharma (uk) ltd - hydroxychloroquine sulfate - oral tablet - 200mg

Estats Units - anglès - NLM (National Library of Medicine)

major pharmaceuticals - hydroxychloroquine sulfate (unii: 8q2869cnvh) (hydroxychloroquine - unii:4qwg6n8qkh) - malaria hydroxychloroquine sulfate is indicated for the treatment of uncomplicated malaria due to p. falciparum, p. malariae, p. ovale, and p. vivax . hydroxychloroquine sulfate is indicated for the prophylaxis of malaria in geographic areas where chloroquine resistance is not reported. limitations of use in malaria • hydroxychloroquine sulfate is not recommended for the treatment of complicated malaria. • hydroxychloroquine sulfate is not effective against chloroquine or hydroxychloroquine-resistant strains of plasmodium species (see clinical pharmacology – microbiology). hydroxychloroquine sulfate is not recommended for the treatment of malaria acquired in geographic areas where chloroquine resistance occurs or when the plasmodium species has not been identified. • hydroxychloroquine sulfate is not recommended for malaria prophylaxis in geographic areas where chloroquine resistance occurs. • hydroxychloroquine sulfate does not prevent relapses of p. vivax or p. ovale because it is not active against th